Literature DB >> 15866232

Diabetes and dietary copper alter 67Cu metabolism and oxidant defense in the rat.

Janet Y Uriu-Adams1, Robert B Rucker, Joel F Commisso, Carl L Keen.   

Abstract

Perturbations in copper (Cu) metabolism are a characteristic of diabetes, for example, elevated plasma Cu and compromised oxidant defense related to diabetes-induced effects on Cu-containing enzymes. Herein, the redistribution of Cu in selected tissues is described in response to diabetic and nondiabetic states in rats that were fed diets adequate in (12 mg Cu/kg of diet) or deficient in (no added Cu) Cu. Diabetes was induced by intravenous administration of streptozotocin (40 mg/kg body weight). After 5 weeks, rats were gavaged with (67)Cu (0.74 MBq per rat) using the Cu-deficient diet as a vehicle (suspended 1:3 in water) and killed at various time points. The use of (67)Cu allowed for the assessment of short-term Cu distribution and its comparison to the steady-state Cu distribution, as determined by direct Cu analysis. In contrast to control rats, the adaptive mechanisms for Cu homeostasis in diabetic rats were impaired. In general, measures of Cu retention were reduced in diabetic rats compared to corresponding values for control rats. Moreover, diabetic rats had low copper, zinc superoxide dismutase activity that was reduced even further when diabetic rats were fed with low-Cu diets. However, liver and kidney metallothionein and plasma ceruloplasmin levels were elevated in diabetic rats compared to control rats. Such diabetes-related metabolic alterations were taken as measures of increased oxidative stress and inflammation, which may have implications in the progression of diabetes-related pathologies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866232     DOI: 10.1016/j.jnutbio.2005.01.007

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  6 in total

1.  Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity.

Authors:  Elizabeth C Lee; Emmeline Ha; Sanghamitra Singh; Linda Legesse; Sana Ahmad; Elena Karnaukhova; Robert P Donaldson; Aleksandar M Jeremic
Journal:  Phys Chem Chem Phys       Date:  2013-08-14       Impact factor: 3.676

2.  α-Amylase and α-glucosidase inhibitor effects and pancreatic response to diabetes mellitus on Wistar rats of Ephedra alata areal part decoction with immunohistochemical analyses.

Authors:  Jihene Ben Lamine; Mouhamed Ali Boujbiha; Sabra Dahane; Amal Ben Cherifa; Aida Khlifi; Hassiba Chahdoura; Mouhamed Taher Yakoubi; Salima Ferchichi; Nacer El Ayeb; Lotfi Achour
Journal:  Environ Sci Pollut Res Int       Date:  2019-02-07       Impact factor: 4.223

Review 3.  Studies on free radicals, antioxidants, and co-factors.

Authors:  Khalid Rahman
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

4.  Interactions between plasma copper concentrations and SOD1 gene polymorphism for impaired glucose regulation and type 2 diabetes.

Authors:  Jiawei Yin; Xiaoqian Wang; Shuzhen Li; Yalun Zhu; Sijing Chen; Peiyun Li; Cheng Luo; Yue Huang; Xiaoqin Li; Xueting Hu; Wei Yang; Wei Bao; Zhilei Shan; Liegang Liu
Journal:  Redox Biol       Date:  2019-03-18       Impact factor: 11.799

Review 5.  The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy.

Authors:  Xiangning Cui; Yan Wang; Han Liu; Mengjun Shi; Jingwu Wang; Yifei Wang
Journal:  Oxid Med Cell Longev       Date:  2022-10-04       Impact factor: 7.310

6.  Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats.

Authors:  Lin Zhang; Marie-Louise Ward; Anthony R J Phillips; Shaoping Zhang; John Kennedy; Bernard Barry; Mark B Cannell; Garth J S Cooper
Journal:  Cardiovasc Diabetol       Date:  2013-08-28       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.